Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azathioprine vs Mesalazine for Prevention of Postoperative Recurrence in Crohn's Disease
NCT00976690Phase 3Completed
- Sponsor
- GETAID
- Start
- Oct 2002
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of azathioprine in Crohn's disease, sponsored by GETAID. Started Oct 2002; status: completed.
02
Drugs
azathioprine
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT00976690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00976690.